Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMINENT
NCT02254824Phase 4Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Xuezhikang in hypertension (HTN), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
Xuezhikang
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02254824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254824.